Annual Interest Expense
$129.18 M
+$38.31 M+42.16%
31 December 2023
Summary:
PTC Therapeutics annual interest expense is currently $129.18 million, with the most recent change of +$38.31 million (+42.16%) on 31 December 2023. During the last 3 years, it has risen by +$72.83 million (+129.24%). PTCT annual interest expense is now at all-time high.PTCT Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$41.61 M
-$1.88 M-4.33%
30 September 2024
Summary:
PTC Therapeutics quarterly interest expense is currently $41.61 million, with the most recent change of -$1.88 million (-4.33%) on 30 September 2024. Over the past year, it has increased by +$13.45 million (+47.76%). PTCT quarterly interest expense is now -6.02% below its all-time high of $44.27 million, reached on 31 December 2023.PTCT Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$170.21 M
+$13.45 M+8.58%
30 September 2024
Summary:
PTC Therapeutics TTM interest expense is currently $170.21 million, with the most recent change of +$13.45 million (+8.58%) on 30 September 2024. Over the past year, it has increased by +$60.80 million (+55.57%). PTCT TTM interest expense is now at all-time high.PTCT TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.2% | +47.8% | +55.6% |
| 3 y3 years | +129.2% | +90.8% | +93.8% |
| 5 y5 years | +929.0% | +1460.7% | +2321.9% |
PTCT Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +129.2% | -6.0% | +99.3% | at high | +97.9% |
| 5 y | 5 years | at high | +934.2% | -6.0% | +1460.7% | at high | +2321.9% |
| alltime | all time | at high | +934.2% | -6.0% | >+9999.0% | at high | >+9999.0% |
PTC Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $41.61 M(-4.3%) | $170.21 M(+8.6%) |
| June 2024 | - | $43.49 M(+6.5%) | $156.76 M(+9.9%) |
| Mar 2024 | - | $40.83 M(-7.8%) | $142.68 M(+10.5%) |
| Dec 2023 | $129.18 M(+42.2%) | $44.27 M(+57.2%) | $129.18 M(+18.1%) |
| Sept 2023 | - | $28.16 M(-4.3%) | $109.41 M(+7.1%) |
| June 2023 | - | $29.41 M(+7.6%) | $102.13 M(+7.9%) |
| Mar 2023 | - | $27.33 M(+11.6%) | $94.69 M(+4.2%) |
| Dec 2022 | $90.87 M(+5.6%) | $24.50 M(+17.3%) | $90.87 M(+2.2%) |
| Sept 2022 | - | $20.88 M(-5.0%) | $88.87 M(-1.0%) |
| June 2022 | - | $21.98 M(-6.5%) | $89.79 M(-0.6%) |
| Mar 2022 | - | $23.51 M(+4.5%) | $90.38 M(+5.1%) |
| Dec 2021 | $86.02 M | $22.50 M(+3.2%) | $86.02 M(-2.0%) |
| Sept 2021 | - | $21.80 M(-3.4%) | $87.81 M(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $22.56 M(+17.7%) | $87.05 M(+24.6%) |
| Mar 2021 | - | $19.16 M(-21.1%) | $69.87 M(+24.0%) |
| Dec 2020 | $56.35 M(+351.1%) | $24.29 M(+15.5%) | $56.35 M(+50.2%) |
| Sept 2020 | - | $21.04 M(+291.1%) | $37.52 M(+95.9%) |
| June 2020 | - | $5.38 M(-4.7%) | $19.15 M(+20.9%) |
| Mar 2020 | - | $5.64 M(+3.3%) | $15.85 M(+26.9%) |
| Dec 2019 | $12.49 M(-0.5%) | $5.46 M(+104.9%) | $12.49 M(+77.7%) |
| Sept 2019 | - | $2.67 M(+28.5%) | $7.03 M(+61.1%) |
| June 2019 | - | $2.07 M(-9.4%) | $4.36 M(+90.6%) |
| Mar 2019 | - | $2.29 M(+582.8%) | $2.29 M(+200.9%) |
| Dec 2018 | $12.55 M | - | - |
| June 2012 | - | $335.10 K(-21.2%) | $760.30 K(+78.8%) |
| Mar 2012 | - | $425.20 K | $425.20 K |
FAQ
- What is PTC Therapeutics annual interest expense?
- What is the all time high annual interest expense for PTC Therapeutics?
- What is PTC Therapeutics annual interest expense year-on-year change?
- What is PTC Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for PTC Therapeutics?
- What is PTC Therapeutics quarterly interest expense year-on-year change?
- What is PTC Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for PTC Therapeutics?
- What is PTC Therapeutics TTM interest expense year-on-year change?
What is PTC Therapeutics annual interest expense?
The current annual interest expense of PTCT is $129.18 M
What is the all time high annual interest expense for PTC Therapeutics?
PTC Therapeutics all-time high annual interest expense is $129.18 M
What is PTC Therapeutics annual interest expense year-on-year change?
Over the past year, PTCT annual interest expense has changed by +$38.31 M (+42.16%)
What is PTC Therapeutics quarterly interest expense?
The current quarterly interest expense of PTCT is $41.61 M
What is the all time high quarterly interest expense for PTC Therapeutics?
PTC Therapeutics all-time high quarterly interest expense is $44.27 M
What is PTC Therapeutics quarterly interest expense year-on-year change?
Over the past year, PTCT quarterly interest expense has changed by +$13.45 M (+47.76%)
What is PTC Therapeutics TTM interest expense?
The current TTM interest expense of PTCT is $170.21 M
What is the all time high TTM interest expense for PTC Therapeutics?
PTC Therapeutics all-time high TTM interest expense is $170.21 M
What is PTC Therapeutics TTM interest expense year-on-year change?
Over the past year, PTCT TTM interest expense has changed by +$60.80 M (+55.57%)